Reports for HYDROCHLOROTHIAZIDE

Ingredient

HYDROCHLOROTHIAZIDE

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-HYDROCHLOROTHIAZIDE 12.5MG TABLET Resolved 2024-03-22 2024-04-26 223083
OLMESARTAN/HCTZ 40MG 25MG TABLET Anticipated shortage 2024-03-26 2024-05-08 223370
OLMESARTAN/HCTZ 40MG 12.5MG TABLET Anticipated shortage 2024-03-26 2024-05-08 223383
OLMESARTAN/HCTZ 20MG 12.5MG TABLET Anticipated shortage 2024-03-26 2024-05-08 223386
SANDOZ LISINOPRIL HCT 25MG 20MG TABLET Actual shortage 2024-04-08 2024-04-09 224639
TEVA-IRBESARTAN HCTZ 300MG 12.5MG TABLET Actual shortage 2024-04-11 2024-05-23 224895
TEVA-IRBESARTAN HCTZ 300MG 25MG TABLET Actual shortage 2024-04-11 2024-05-23 224898
TEVA-TELMISARTAN HCTZ 25.0MG 80.0MG TABLET Actual shortage 2024-04-11 2024-05-23 224901
CANDESARTAN/HCTZ 12.5MG 16MG TABLET Actual shortage 2024-04-22 2024-04-23 225881
CANDESARTAN-HCTZ 12.5MG 16.0MG TABLET Resolved 2024-05-03 2024-05-16 227037

Showing 661 to 670 of 674

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-VALSARTAN/HCTZ Discontinued 2019-01-03 2019-01-03 71051
APO-VALSARTAN/HCTZ 12.5MG 160MG TABLET Discontinued 2019-01-03 2019-01-03 71054
APO-VALSARTAN/HCTZ Discontinued 2019-01-03 2019-01-03 71057
APO-LOSARTAN/HCTZ 12.5MG 50MG TABLET Discontinued 2019-01-03 2019-01-03 71101
RAMIPRIL-HCTZ 12.5MG 10.0MG TABLET Discontinued 2019-04-10 2019-04-11 81148
RAMIPRIL-HCTZ 25.0MG 10.0MG TABLET Discontinued 2019-04-10 2019-04-11 81151
TEVA-LISINOPRIL/HCTZ (TYPE P) 12.5MG 20MG TABLET Discontinued 2019-04-11 2019-04-11 81301
TEVA-LISINOPRIL/HCTZ (TYPE P) 25MG 20MG TABLET Discontinued 2019-04-11 2019-04-11 81368
VALSARTAN HCT 25MG 320MG TABLET Discontinued 2019-09-18 2020-01-09 94211
ALDACTAZIDE 25 25MG 25MG TABLET Discontinued 2019-10-01 2020-04-13 95153

Showing 61 to 70 of 102